FHLC holdings
Fidelity MSCI Health Care Index ETF
Positions
337 stored of 337 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 201 | Agios Pharmaceuticals Inc | US00847X1046 | 00847X104 | 0.025% | $807K | Equity (common) | Corporate | United States | USD |
| 202 | Establishment Labs Holdings Inc | VGG312491084 | Not reported | 0.024% | $805K | Equity (common) | Corporate | British Virgin Islands | USD |
| 203 | AtaiBeckley Inc | US04650F1012 | 04650F101 | 0.024% | $805K | Equity (common) | Corporate | United States | USD |
| 204 | CorVel Corp | US2210061097 | 221006109 | 0.024% | $803K | Equity (common) | Corporate | United States | USD |
| 205 | Harmony Biosciences Holdings Inc | US4131971040 | 413197104 | 0.024% | $799K | Equity (common) | Corporate | United States | USD |
| 206 | Newamsterdam Pharma Co NV | NL00150012L7 | Not reported | 0.024% | $797K | Equity (common) | Corporate | Netherlands | USD |
| 207 | Biohaven Ltd | VGG1110E1079 | Not reported | 0.024% | $796K | Equity (common) | Corporate | British Virgin Islands | USD |
| 208 | Enovis Corp | US1940145022 | 194014502 | 0.024% | $787K | Equity (common) | Corporate | United States | USD |
| 209 | VeraDermics Inc | US9229671048 | 922967104 | 0.023% | $771K | Equity (common) | Corporate | United States | USD |
| 210 | Syndax Pharmaceuticals Inc | US87164F1057 | 87164F105 | 0.023% | $768K | Equity (common) | Corporate | United States | USD |
| 211 | Astrana Health Inc | US03763A2078 | 03763A207 | 0.023% | $765K | Equity (common) | Corporate | United States | USD |
| 212 | Aurinia Pharmaceuticals Inc | CA05156V1022 | 05156V102 | 0.023% | $752K | Equity (common) | Corporate | Canada | USD |
| 213 | Omnicell Inc | US68213N1090 | 68213N109 | 0.023% | $745K | Equity (common) | Corporate | United States | USD |
| 214 | Nuvation Bio Inc | US67080N1019 | 67080N101 | 0.022% | $730K | Equity (common) | Corporate | United States | USD |
| 215 | Novocure Ltd | JE00BYSS4X48 | Not reported | 0.022% | $722K | Equity (common) | Corporate | Jersey | USD |
| 216 | UroGen Pharma Ltd | IL0011407140 | Not reported | 0.022% | $710K | Equity (common) | Corporate | Israel | USD |
| 217 | Innoviva Inc | US45781M1018 | 45781M101 | 0.021% | $703K | Equity (common) | Corporate | United States | USD |
| 218 | ANI Pharmaceuticals Inc | US00182C1036 | 00182C103 | 0.021% | $698K | Equity (common) | Corporate | United States | USD |
| 219 | Sarepta Therapeutics Inc | US8036071004 | 803607100 | 0.021% | $697K | Equity (common) | Corporate | United States | USD |
| 220 | Viridian Therapeutics Inc | US92790C1045 | 92790C104 | 0.021% | $695K | Equity (common) | Corporate | United States | USD |
| 221 | Amylyx Pharmaceuticals Inc | US03237H1014 | 03237H101 | 0.021% | $693K | Equity (common) | Corporate | United States | USD |
| 222 | Perrigo Co PLC | IE00BGH1M568 | Not reported | 0.021% | $685K | Equity (common) | Corporate | Ireland | USD |
| 223 | MBX Biosciences Inc | US55287L1017 | 55287L101 | 0.021% | $684K | Equity (common) | Corporate | United States | USD |
| 224 | Nurix Therapeutics Inc | US67080M1036 | 67080M103 | 0.021% | $684K | Equity (common) | Corporate | United States | USD |
| 225 | CONMED Corp | US2074101013 | 207410101 | 0.021% | $679K | Equity (common) | Corporate | United States | USD |
| 226 | Iovance Biotherapeutics Inc | US4622601007 | 462260100 | 0.021% | $677K | Equity (common) | Corporate | United States | USD |
| 227 | Palvella Therapeutics Inc | US6979471090 | 697947109 | 0.021% | $676K | Equity (common) | Corporate | United States | USD |
| 228 | Mineralys Therapeutics Inc | US6031701013 | 603170101 | 0.021% | $675K | Equity (common) | Corporate | United States | USD |
| 229 | Recursion Pharmaceuticals Inc | US75629V1044 | 75629V104 | 0.020% | $670K | Equity (common) | Corporate | United States | USD |
| 230 | Vera Therapeutics Inc | US92337R1014 | 92337R101 | 0.020% | $653K | Equity (common) | Corporate | United States | USD |
| 231 | Intellia Therapeutics Inc | US45826J1051 | 45826J105 | 0.020% | $651K | Equity (common) | Corporate | United States | USD |
| 232 | Xeris Biopharma Holdings Inc | US98422E1038 | 98422E103 | 0.020% | $649K | Equity (common) | Corporate | United States | USD |
| 233 | Celcuity Inc | US15102K1007 | 15102K100 | 0.020% | $645K | Equity (common) | Corporate | United States | USD |
| 234 | Pennant Group Inc/The | US70805E1091 | 70805E109 | 0.019% | $636K | Equity (common) | Corporate | United States | USD |
| 235 | Tandem Diabetes Care Inc | US8753722037 | 875372203 | 0.019% | $633K | Equity (common) | Corporate | United States | USD |
| 236 | AMN Healthcare Services Inc | US0017441017 | 001744101 | 0.019% | $625K | Equity (common) | Corporate | United States | USD |
| 237 | Inspire Medical Systems Inc | US4577301090 | 457730109 | 0.019% | $618K | Equity (common) | Corporate | United States | USD |
| 238 | GeneDx Holdings Corp | US81663L2007 | 81663L200 | 0.019% | $616K | Equity (common) | Corporate | United States | USD |
| 239 | Kodiak Sciences Inc | US50015M1099 | 50015M109 | 0.019% | $611K | Equity (common) | Corporate | United States | USD |
| 240 | BioLife Solutions Inc | US09062W2044 | 09062W204 | 0.018% | $601K | Equity (common) | Corporate | United States | USD |
| 241 | Butterfly Network Inc | US1241551027 | 124155102 | 0.018% | $598K | Equity (common) | Corporate | United States | USD |
| 242 | US Physical Therapy Inc | US90337L1089 | 90337L108 | 0.018% | $596K | Equity (common) | Corporate | United States | USD |
| 243 | Surgery Partners Inc | US86881A1007 | 86881A100 | 0.018% | $589K | Equity (common) | Corporate | United States | USD |
| 244 | Harrow Inc | US4158581094 | 415858109 | 0.018% | $586K | Equity (common) | Corporate | United States | USD |
| 245 | Ocular Therapeutix Inc | US67576A1007 | 67576A100 | 0.018% | $584K | Equity (common) | Corporate | United States | USD |
| 246 | Precigen Inc | US74017N1054 | 74017N105 | 0.018% | $580K | Equity (common) | Corporate | United States | USD |
| 247 | Guardian Pharmacy Services Inc | US40145W1018 | 40145W101 | 0.017% | $571K | Equity (common) | Corporate | United States | USD |
| 248 | Teladoc Health Inc | US87918A1051 | 87918A105 | 0.017% | $560K | Equity (common) | Corporate | United States | USD |
| 249 | Artivion Inc | US2289031005 | 228903100 | 0.017% | $548K | Equity (common) | Corporate | United States | USD |
| 250 | QuidelOrtho Corp | US2197981051 | 219798105 | 0.017% | $546K | Equity (common) | Corporate | United States | USD |
| 251 | MannKind Corp | US56400P7069 | 56400P706 | 0.017% | $546K | Equity (common) | Corporate | United States | USD |
| 252 | Azenta Inc | US1143401024 | 114340102 | 0.017% | $543K | Equity (common) | Corporate | United States | USD |
| 253 | Integra LifeSciences Holdings Corp | US4579852082 | 457985208 | 0.016% | $541K | Equity (common) | Corporate | United States | USD |
| 254 | Ardelyx Inc | US0396971071 | 039697107 | 0.016% | $539K | Equity (common) | Corporate | United States | USD |
| 255 | Rapport Therapeutics Inc | US75383L1026 | 75383L102 | 0.016% | $535K | Equity (common) | Corporate | United States | USD |
| 256 | Collegium Pharmaceutical Inc | US19459J1043 | 19459J104 | 0.016% | $535K | Equity (common) | Corporate | United States | USD |
| 257 | Alphatec Holdings Inc | US02081G2012 | 02081G201 | 0.016% | $531K | Equity (common) | Corporate | United States | USD |
| 258 | Taysha Gene Therapies Inc | US8776191061 | 877619106 | 0.016% | $513K | Equity (common) | Corporate | United States | USD |
| 259 | First Tracks Biotherapeutics Inc | US3371851029 | 337185102 | 0.015% | $509K | Equity (common) | Corporate | United States | USD |
| 260 | Stoke Therapeutics Inc | US86150R1077 | 86150R107 | 0.015% | $507K | Equity (common) | Corporate | United States | USD |
| 261 | Damora Therapeutics Inc | KYG2646Y1044 | Not reported | 0.015% | $499K | Equity (common) | Corporate | Cayman Islands | USD |
| 262 | Procept Biorobotics Corp | US74276L1052 | 74276L105 | 0.015% | $486K | Equity (common) | Corporate | United States | USD |
| 263 | Vir Biotechnology Inc | US92764N1028 | 92764N102 | 0.015% | $483K | Equity (common) | Corporate | United States | USD |
| 264 | Novavax Inc | US6700024010 | 670002401 | 0.014% | $472K | Equity (common) | Corporate | United States | USD |
| 265 | Pacira BioSciences Inc | US6951271005 | 695127100 | 0.014% | $470K | Equity (common) | Corporate | United States | USD |
| 266 | Certara Inc | US15687V1098 | 15687V109 | 0.014% | $466K | Equity (common) | Corporate | United States | USD |
| 267 | Schrodinger Inc/United States | US80810D1037 | 80810D103 | 0.014% | $463K | Equity (common) | Corporate | United States | USD |
| 268 | HeartFlow Inc | US42238D1072 | 42238D107 | 0.014% | $463K | Equity (common) | Corporate | United States | USD |
| 269 | AdaptHealth Corp | US00653Q1022 | 00653Q102 | 0.013% | $436K | Equity (common) | Corporate | United States | USD |
| 270 | EyePoint Inc | US30233G2093 | 30233G209 | 0.013% | $430K | Equity (common) | Corporate | United States | USD |
| 271 | Xencor Inc | US98401F1057 | 98401F105 | 0.013% | $426K | Equity (common) | Corporate | United States | USD |
| 272 | Personalis Inc | US71535D1063 | 71535D106 | 0.012% | $409K | Equity (common) | Corporate | United States | USD |
| 273 | AnaptysBio Inc | US0327241065 | 032724106 | 0.012% | $401K | Equity (common) | Corporate | United States | USD |
| 274 | Zymeworks Inc | US98985Y1082 | 98985Y108 | 0.012% | $401K | Equity (common) | Corporate | United States | USD |
| 275 | Corvus Pharmaceuticals Inc | US2210151005 | 221015100 | 0.012% | $397K | Equity (common) | Corporate | United States | USD |
| 276 | Zenas Biopharma Inc | US98937L1052 | 98937L105 | 0.012% | $396K | Equity (common) | Corporate | United States | USD |
| 277 | Jade Biosciences Inc | US0080642061 | 008064206 | 0.012% | $390K | Equity (common) | Corporate | United States | USD |
| 278 | Bicara Therapeutics Inc | US0554771032 | 055477103 | 0.012% | $389K | Equity (common) | Corporate | United States | USD |
| 279 | Omeros Corp | US6821431029 | 682143102 | 0.012% | $385K | Equity (common) | Corporate | United States | USD |
| 280 | MoonLake Immunotherapeutics | KY61559X1045 | 61559X104 | 0.012% | $380K | Equity (common) | Corporate | Cayman Islands | USD |
| 281 | SI-BONE Inc | US8257041090 | 825704109 | 0.011% | $377K | Equity (common) | Corporate | United States | USD |
| 282 | Monte Rosa Therapeutics Inc | US61225M1027 | 61225M102 | 0.011% | $377K | Equity (common) | Corporate | United States | USD |
| 283 | iRadimed Corp | US46266A1097 | 46266A109 | 0.011% | $361K | Equity (common) | Corporate | United States | USD |
| 284 | Castle Biosciences Inc | US14843C1053 | 14843C105 | 0.011% | $348K | Equity (common) | Corporate | United States | USD |
| 285 | Phibro Animal Health Corp | US71742Q1067 | 71742Q106 | 0.011% | $347K | Equity (common) | Corporate | United States | USD |
| 286 | ArriVent Biopharma Inc | US04272N1028 | 04272N102 | 0.010% | $345K | Equity (common) | Corporate | United States | USD |
| 287 | STAAR Surgical Co | US8523123052 | 852312305 | 0.010% | $344K | Equity (common) | Corporate | United States | USD |
| 288 | Nutex Health Inc | US67079U3068 | 67079U306 | 0.010% | $342K | Equity (common) | Corporate | United States | USD |
| 289 | WaVe Life Sciences Ltd | SG9999014716 | Not reported | 0.010% | $340K | Equity (common) | Corporate | Singapore | USD |
| 290 | Aveanna Healthcare Holdings Inc | US05356F1057 | 05356F105 | 0.010% | $340K | Equity (common) | Corporate | United States | USD |
| 291 | Tyra Biosciences Inc | US90240B1061 | 90240B106 | 0.010% | $338K | Equity (common) | Corporate | United States | USD |
| 292 | Kura Oncology Inc | US50127T1097 | 50127T109 | 0.010% | $319K | Equity (common) | Corporate | United States | USD |
| 293 | HealthStream Inc | US42222N1037 | 42222N103 | 0.010% | $319K | Equity (common) | Corporate | United States | USD |
| 294 | MeiraGTx Holdings plc | KYG596651029 | Not reported | 0.009% | $311K | Equity (common) | Corporate | Cayman Islands | USD |
| 295 | Geron Corp | US3741631036 | 374163103 | 0.009% | $306K | Equity (common) | Corporate | United States | USD |
| 296 | Amphastar Pharmaceuticals Inc | US03209R1032 | 03209R103 | 0.009% | $306K | Equity (common) | Corporate | United States | USD |
| 297 | Sionna Therapeutics Inc | US8294011080 | 829401108 | 0.009% | $302K | Equity (common) | Corporate | United States | USD |
| 298 | Theravance Biopharma Inc | KYG8807B1068 | Not reported | 0.009% | $302K | Equity (common) | Corporate | Cayman Islands | USD |
| 299 | Maze Therapeutics Inc | US5787841007 | 578784100 | 0.009% | $300K | Equity (common) | Corporate | United States | USD |
| 300 | Cullinan Therapeutics Inc | US2300311063 | 230031106 | 0.009% | $297K | Equity (common) | Corporate | United States | USD |